Liver Diseases and Transplantation
Hepatologists discuss goals, challenges of treating alcoholic liver disease
Alcoholic liver disease (ALD) is one of the leading causes of morbidity and mortality in the U.S. and worldwide. Three hepatologists discussed the management of patients with alcoholic hepatitis (AH) and how to diagnose and treat alcohol use in patients with ALD during an AASLD symposium on Monday, May 8, at DDW® 2017. Acco... Read more
Experts explore medical and surgical management of portal hypertension
An AASLD symposium on the final day of DDW® 2017 brought together experts from around the world to discuss pharmacological therapies, endoscopic therapies, interventional procedures and the surgical management of portal hypertension (PH) in patients with alcoholic liver disease (ALD). “Beta blockers are still the mainstay o... Read more
Texting can be good for your health
Studies have shown that success in losing weight is affected by how often patients see a health-care professional. Patients benefit from the doctor’s advice and reminders on nutrition, exercise, stress management, time management and tips on finding healthy, affordable food. Regrettably, though, most patients only see their... Read more
Hospitalized cirrhotic patients present multiple treatment challenges
Patients who are hospitalized with cirrhosis are in trouble. They may have hepatic encephalopathy leading to impaired mentation and possible coma. They may have acute kidney injury that requires a liver transplant. They may have portal hypertension leading to ascites and spontaneous bacterial peritonitis. And they may have... Read more
AASLD symposium will highlight role of nutrition in pediatric liver disease
Adequate nutrition is important for growth and meeting developmental milestones for all children. But for pediatric liver patients, overnutrition or undernutrition can have devastating effects. Read more
Award lecturer will discuss efforts to eliminate viral hepatitis through vaccination
Can viral hepatitis be eliminated? That’s the key question to be addressed Monday at the annual AGA Emmet B. Keeffe Symposium, Prevention of Viral Hepatitis Through Vaccination: Done or Just Getting Started? Read more
Experts to discuss disease progression, treatment options for NAFLD, NASH
Four experts will discuss the management for nonalcoholic fatty liver disease (NAFLD) and its progression to nonalcoholic steatohepatitis (NASH) during Tuesday’s AASLD Clinical Symposium Identification and Management of Patients with NAFLD/NASH. Read more
New agents redefine treatment options for HCC patients
The management of hepatocellular cancer (HCC) saw meaningful advances in 2016 with the introduction of two compounds, regorafenib and lenvatinib, for patients with advanced HCC. Read more
Cirrhosis complicates decision-making when patients need liver surgery
Four experts will discuss key considerations when making surgical decisions for cirrhotic patients during Tuesday’s DDW® Clinical Symposium, Cirrhosis and Surgery: Identifying and Managing, which is co-sponsored by AASLD and SSAT. Symposium co-chair Shimul Shah, MD, MHCM, associate professor of surgery and director of liver... Read more
Expert will discuss strategies to optimize treatment response for challenging hep C patients who fail therapy
Current treatments for hepatitis C virus (HCV) are quite effective, with a cure rate inching toward 100 percent. However, there are certain subpopulations that fail direct-acting antiviral (DAA) therapy and others who have yet to be diagnosed — up to 50 percent of people with the virus, according to some estimates. Read more